the continuous increase in the prices of input raw materials as well as the increase in the cost of production and transport of medicines are in direct contrast to the ongoing price reduction of generic and biosimilar drugs in the Slovak Republic. The consequence is a rising shortage of medicines for patients. Even a short interruption in the availability of medicines can have a major impact on a patient’s health and life. Every patient has a right to certain access to the medicines they need. This access is a fundamental aspect of providing quality healthcare.